Gland Pharma shares zoom 20% as Q1 growth triggers upgrades
Shares of Gland Pharma on Tuesday rallied up to 20% to the day’s high of Rs 1,610 after the company reported better-than-expected June quarter earnings with revenue growing 41% year-on-year (YoY). Global brokerage firm Jefferies upgraded the stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier. Bernstein … Read more